ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Yizhi Wang
Matched on ORCID iD 0009-0008-1449-8424; OpenAlex author ID A5101969073. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 4 papers · 2021: 3 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 9
- Integration of bulk and single-cell transcriptomic data reveals a novel signature related to liver metastasis and basement membrane in pancreatic cancer. Last author DOI 10.3389/fimmu.2025.1671956↗
- Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis. Co-author DOI 10.1186/s40001-024-01823-6↗
- Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer. Co-author DOI 10.1080/00365521.2020.1853806↗
- Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Metalloproteinase 9 in Resectable Pancreatic… Co-author DOI 10.1097/mpa.0000000000001892↗
- Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transforming growth factor-β receptors in patients… Co-author DOI 10.1111/jgh.15244↗
- Photodynamic therapy of pancreatic cancer: Where have we come from and where are we going? Co-author DOI 10.1016/j.pdpdt.2020.101876↗
- Transducin-Like Enhancer of Split-1 Inhibits Malignant Behaviors in vitro and Predicts a Better Prognosis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.00576↗
- Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review. Co-author DOI 10.3389/fonc.2020.01466↗
- Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? Co-author DOI 10.3389/fonc.2020.576399↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bolun Jiang · 7 shared papers, 2020–2021 · strength 0.91
- Paper Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer. DOI 10.1080/00365521.2020.1853806↗
- Paper Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Meta… DOI 10.1097/mpa.0000000000001892↗
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244↗
- Li Zhou · 7 shared papers, 2020–2021 · strength 0.91
- Paper Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer. DOI 10.1080/00365521.2020.1853806↗
- Paper Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Meta… DOI 10.1097/mpa.0000000000001892↗
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244↗
- Jun Lü · 7 shared papers, 2020–2021 · strength 0.91
- Paper Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer. DOI 10.1080/00365521.2020.1853806↗
- Paper Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Meta… DOI 10.1097/mpa.0000000000001892↗
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244↗
- Junchao Guo · 5 shared papers, 2020–2021 · strength 0.65
- Paper Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer. DOI 10.1080/00365521.2020.1853806↗
- Paper Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Meta… DOI 10.1097/mpa.0000000000001892↗
- Paper Photodynamic therapy of pancreatic cancer: Where have we come from and where are we going? DOI 10.1016/j.pdpdt.2020.101876↗
- Dongkai Zhou · 2 shared papers, 2024–2025 · strength 0.61
- Paper Integration of bulk and single-cell transcriptomic data reveals a novel signature related to liver metastasis and basem… DOI 10.3389/fimmu.2025.1671956↗
- Paper Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancre… DOI 10.1186/s40001-024-01823-6↗
- Lei You · 4 shared papers, 2020–2021 · strength 0.51
- Paper Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Meta… DOI 10.1097/mpa.0000000000001892↗
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244↗
- Paper Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? DOI 10.3389/fonc.2020.576399↗
- Zhiyong Liang · 3 shared papers, 2020–2021 · strength 0.38
- Paper Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Meta… DOI 10.1097/mpa.0000000000001892↗
- Paper Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transformi… DOI 10.1111/jgh.15244↗
- Paper Transducin-Like Enhancer of Split-1 Inhibits Malignant Behaviors in vitro and Predicts a Better Prognosis in Pancreatic… DOI 10.3389/fonc.2020.00576↗
- Junchao Guo · 1 shared paper, 2021 · strength 0.13
- Xi Zoë Zhong · 1 shared paper, 2020 · strength 0.13
- Junchao Guo · 1 shared paper, 2020 · strength 0.13
- Yu-Pei Zhao · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.